Literature DB >> 1653913

Glycine prodrug facilitates memory retrieval in humans.

B L Schwartz1, S Hashtroudi, R L Herting, H Handerson, S I Deutsch.   

Abstract

Modulation of glycine concentrations in the brain influences learning and memory functions in experimental animals. We administered milacemide, a glycine prodrug, or placebo to young and older healthy adults, who performed a word-retrieval task. Milacemide administration increased the number of words retrieved and decreased the latency with which these words were retrieved for both young and older adults.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653913     DOI: 10.1212/wnl.41.9.1341

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

Review 1.  Cognition enhancers in age-related cognitive decline.

Authors:  W J Riedel; J Jolles
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

2.  Cognitive effects of milacemide and methylphenidate in healthy young adults.

Authors:  J A Camp-Bruno; R L Herting
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

Review 3.  Glutamate: its role in learning, memory, and the aging brain.

Authors:  W J McEntee; T H Crook
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  A glycinergic intervention potentiates the antiseizure efficacies of MK-801, flurazepam, and carbamazepine.

Authors:  D O Norris; J Mastropaolo; D A O'Connor; J M Cohen; S I Deutsch
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

5.  Acute high-dose glycine attenuates mismatch negativity (MMN) in healthy human controls.

Authors:  Sumie Leung; Rodney J Croft; Barry V O'Neill; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2007-10-20       Impact factor: 4.530

6.  Kynurenic acid and 5,7-dichlorokynurenic acids improve social and object recognition in male rats.

Authors:  Z Hlinák; I Krejci
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

Review 7.  The glutamatergic system and Alzheimer's disease: therapeutic implications.

Authors:  D Allan Butterfield; Chava B Pocernich
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

8.  Glutamate, learning and dementia-selection of evidence.

Authors:  W Danysz; T Archer
Journal:  Amino Acids       Date:  1994-06       Impact factor: 3.520

9.  Therapeutic approaches to age-associated neurocognitive disorders.

Authors:  R O'Hara; C Derouesné; K N Fountoulakis; J A Yesavage
Journal:  Dialogues Clin Neurosci       Date:  2001-09       Impact factor: 5.986

10.  Polymorphism in the LASP1 gene promoter region alters cognitive functions of patients with schizophrenia.

Authors:  Chieh-Hsin Lin; Sheng Yang; Yu-Jhen Huang; Hsien-Yuan Lane
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.